obesity-995x60.png
FEATURED ARTICLES
Contracting For AI In Clinical Trials: Cybersecurity, Monitoring, And Risk Allocation (Part 3)
Leibowitz Law shares the third installment of its three-part series on contracting for AI in clinical trial operations. Part 3 picks up with cybersecurity, monitoring and validation, and risk allocation.
-
![Mother abd adult daughter at doctors-GettyImages-2213748134]( "Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study")
Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS StudyBeing time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.
-
![LauraODonnell]( "Why Site Engagement Isn't Just A Role Anymore")
Why Site Engagement Isn't Just A Role AnymoreGSK’s Laura O'Donnell says site engagement is no longer just a function or team, it’s an organization-wide capability. In this article, she discusses why the traditional CRA relationship model has broken down, how sponsors are using data and AI to better support sites, and why human connection still matters in an increasingly automated clinical trial environment.
-
![build trust-GettyImages-1175873327]( "It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust")
It's A Fact: Sharing Clinical Trial Results With Participants Builds TrustCISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.
SERVICES AND PRODUCTS
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
Digital health technologies have the potential to transform clinical trials, yet without careful planning and support, their implementation can increase site burden and jeopardize data quality.
Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.